buserelin

Ligand id: 3860

Name: buserelin

Structure and Physico-chemical Properties

2D Structure
Classification
Compound class Peptide or derivative
Approved drug? Yes
IUPAC Name
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
International Nonproprietary Names
INN number INN
4045 buserelin
Synonyms
buserelin acetate | HOE 766 | HOE 766A | ICI 123215 | Metrelef® | Suprefact®
Comments
Buserelin is a GnRH (luteinizing hormone-releasing hormone, LHRH) agonist. Buserelin does not appear to have marketing approval for human use in the US or EU, although individual countries may have approved use of this drug.
Database Links
CAS Registry No. 57982-77-1 (source: Scifinder)
ChEMBL Ligand CHEMBL2110824
DrugBank Ligand DB06719
GtoPdb PubChem SID 178100699
PubChem CID 50225
Search Google for chemical match using the InChIKey CUWODFFVMXJOKD-UVLQAERKSA-N
Search Google for chemicals with the same backbone CUWODFFVMXJOKD
Search PubMed clinical trials buserelin
Search PubMed titles buserelin
Search PubMed titles/abstracts buserelin
Search UniChem for chemical match using the InChIKey CUWODFFVMXJOKD-UVLQAERKSA-N
Search UniChem for chemicals with the same backbone CUWODFFVMXJOKD
Wikipedia Buserelin